Table 5.
Comparison of monthly UHD use at 6 month follow-up between 'GP' and 'GNP' groups.
| Unadjusted | Adjusted* | |||||
|---|---|---|---|---|---|---|
| GP (n = 86) |
GNP (n = 89) |
GP -- GNP | GP -- GNP | |||
| Drug pattern in months | Mean score (SD) | Mean difference (95% CI) |
p-value | Mean difference (95% CI) |
p-value | |
| Full dose PPI | 2.0 (2.7) | 0.6 (1.7) | 1.4 (0.8, 2.1) | < 0.001 | 1.5 (0.8, 2.1) | < 0.001 |
| Half dose PPIs | 1.5 (2.4) | 1.4 (2.3) | 0.0 (-0.7, 0.7) | 0.942 | 0.1 (-0.5, 0.8) | 0.702 |
| No treatment | 2.5 (2.7) | 4.0 (2.5) | -1.5 (-2.2, -0.7) | < 0.001 | -1.7 (-2.4, -0.9) | < 0.001 |
* Adjusted for baseline level.
† Including all H2RAs.